Abstracts

Variable HIV-1 C Env Characteristics Associated With Predicted bNAb Resistance in Botswana

Background: Characterizing HIV-1 early founder viruses is essential for informing vaccine design and broadly neutralizing antibody (bnAb) design. We analyzed variable region characteristics (VC) in HIV-1 seroconverters and compared them with predicted bnAb resistance/sensitivity using machine learning techniques. Methods: We analyzed HIV-1 near-full-length proviral sequences from 140 adults with documented recent HIV-1 seroconversion who were…

Persons With Residual Viremia on ART Have Higher Frequencies of Myeloid-Derived Suppressor Cells

Background: Myeloid-derived suppressor cells (MDSC) are a heterogenous population that suppress T, B, and NK cell function through multiple mechanisms and expand with acute and chronic inflammatory conditions. We evaluated whether frequencies of MDSC are associated with measures of HIV persistence and levels of inflammation in persons with HIV (PWH) on long-term ART. Methods: In…

Low SKAP1 Levels Indicate a Potential New Mechanism in HIV Immunological Non-Responders

Background: Immunological non-responders (INRs) are people living with HIV (PLHIV) who fail to adequately restore CD4+ T-cell levels during suppressive ART. In contrast, immunological responders (IRs) do achieve CD4+ T-cell levels comparable to healthy individuals. Morbidity and mortality are increased in INRs. However, the pathogenesis of INRs is multifactorial and not fully elucidated yet. In…

Plasma Proteome Signature of Immune Inhibition Is Associated With CMV Coinfection in People With HIV

Background: Cytomegalovirus (CMV) coinfection is highly prevalent and is associated with persistent inflammation in people with HIV (PWH). A comprehensive analysis of the plasma proteome in PWH with or without CMV has never been performed previously. Identifying proteomic signatures of CMV infection in PWH will improve understanding of CMV-associated comorbidities in PWH and may lead…

Identification of a New Class of Capsid-Targeting Inhibitors That Specifically Block Nuclear Import

Background: Nuclear localized viral genomes account for the persistence HIV-1 in patients despite successful antiretroviral therapy. Drugs that target reverse transcription or integration do not prevent HIV from reaching the nucleus and producing viral transcripts and proteins. Inhibiting HIV-1 nuclear import could make a significant contribution by reducing the reservoir. Methods: A total of 85…

Validation and Acceptability of SARS-CoV-2 Loop-Mediated Isothermal Amplification Test in Malawi

Background: Real-time-reverse-transcription-Polymerase-Chain-Reaction (RT-PCR) is the gold-standard diagnostic test to confirm SARS-CoV-2 infection however RT-PCR is expensive requiring specialist laboratories. Alternatively, optimised nucleic-acid-tests such as SARS-CoV-2-reverse-transcriptase-Loop-mediated-isothermal-AMPlification (SARS-LAMP) could minimise costs and enable testing in settings without specialist laboratories. We evaluated the diagnostic test accuracy (DTA)-(sensitivity detecting cycle-threshold (CT) values 95%), acceptability and user-friendliness of SARS-LAMP test.…

CSF HIV Viral Escape Is Associated With Improved Survival in Adults With HIV-Associated Meningitis

Background: Cryptococcal meningitis and tuberculous meningitis (TBM) remain the most common causes of HIV-associated meningitis, accounting for >20% of AIDS-related deaths globally. Acute mortality associated with these infectious meningitides remains devastatingly high (25-50%), even in the context of clinical trials. We hypothesised that cerebrospinal fluid (CSF) HIV viral escape may contribute to central nervous system…

Single Cell Transcriptomics Reveals Depletion of TB-Specific Th1 and Th17 Cells After HIV Infection

Background: HIV substantially increases the risk of progression of Mycobacterium tuberculosis (Mtb) infection to active tuberculosis (TB) disease. This heightened risk of developing TB persists even in people with suppressed viral loads on long-term antiretroviral therapy (ART). The mechanisms underlying the loss of immune control of Mtb in people with HIV (PWH) remains unclear. We…